TechnologyTangle Logo
TechnologyTangle
HomeUncategorizedA 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study - The Lancet

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study - The Lancet

UncategorizedFebruary 4, 2023
1 min read
[ad_1]\r\nA 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study  The LancetL
[ad_1]\r\n
  1. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study  The Lancet
  2. Leiden study shows adjusting drug doses to patient DNA cuts side effects - DutchNews.nl  DutchNews.nl
  3. Matching medicine dosage to patient\'s DNA can cut side effects 30%: LUMC  NL Times
  4. View Full coverage on Google News
\r\n
[ad_2]\r\n
Source link

Share this article

Related Articles

TechnologyTangle
2026 • Jan 07

Building materials are getting closer to doubling as batteries

Concrete already builds our world, and an MIT-invented variant known as electron-­conducting carbon concrete (ec3, pronounced “e c cubed”) holds out the possibility of helping power it, too. Now that ...

Article2 min read
Read More